8th Annual: Commercial Translation of Regenerative Medicine 2010

Optimise cell product quality and overcome regulatory, reimbursement and funding challenges within successful clinical trials.

In the Chair:
Prof. Chris Mason
Stem Cell and Regenerative Medicine Bioprocessing Unit, Advanced Centre for Biochemical Engineering
University College London, UK

This 8th annual marcus evans conference will provide invaluable knowledge to develop business strategies to accomodate global pricing and reimbursement challenges and attract funding. Attendees will receive key industry and regulatory insight into improving cell product quality and evaluate the best methods available for cell delivery.

This in turn will identify the link to translate your product from research phase into commercial clinical use, developing funding opportunities to excel in this breakthrough market.

Further Information: http://www.melifesciences.com/RegenMed